SkyCell, a Swiss-based technology firm seeking to change the face of global pharmaceutical supply chains, has received a US$57m investment from M&G Investments. The investment will support SkyCell’s continued international…
SkyCell, a Swiss-based technology firm seeking to change the face of global pharmaceutical supply chains, has received a US$57m investment from M&G Investments. The investment will support SkyCell’s continued international…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference